• Palvella Therapeutics Chief Scientific Officer Jeffrey S. Martini sold 12,500 common shares on Nov. 10-11, 2026.
• Martini exercised stock options for 4,266 shares at $7.53 per share and 8,234 shares at $9.79 per share.
• Following the transactions, he held no common shares directly; remaining stock options covered 36,141 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-126376), on November 12, 2026, and is solely responsible for the information contained therein.